Previous Article | Next Article 
Journal of Virology, March 2002, p. 2890-2898, Vol. 76, No. 6
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.6.2890-2898.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Distinct Glycoprotein O Complexes Arise in a Post-Golgi Compartment of Cytomegalovirus-Infected Cells
Regan N. Theiler and Teresa Compton*
McArdle Laboratory for Cancer Research, University of Wisconsin-Madison Medical School, Madison, Wisconsin 53706
Received 26 September 2001/
Accepted 7 December 2001
Human cytomegalovirus (CMV) glycoproteins H, L, and O (gH, gL, and gO, respectively) form a heterotrimeric disulfide-bonded complex that participates in the fusion of the viral envelope with the host cell membrane. During virus maturation, this complex undergoes a series of intracellular assembly and processing events which are not entirely defined (M. T. Huber and T. Compton, J. Virol. 73:3886-3892, 1999). Here, we demonstrate that gO does not undergo the same posttranslational processing in transfected cells as it does in infected cells. We further determined that gO is modified by O-linked glycosylation and that this terminally processed form is highly enriched in virions. However, during studies of gO processing, novel gO complexes were discovered in CMV virions. The newly identified gO complexes, including gO-gL heterodimers, were not readily detected in CMV-infected cells. Further characterization of the trafficking of gO through the secretory pathway of infected cells localized gH, gL, and gO primarily to the Golgi apparatus and trans-Golgi network, supporting the conclusion that the novel virion-associated gO complexes arise in a post-Golgi compartment of infected cells.
* Corresponding author. Mailing address: McArdle Laboratory for Cancer Research, 1400 University Ave., Madison, WI 53706. Phone: (608) 262-1474. Fax: (608) 262-2824. E-mail:
tcompton{at}facstaff.wisc.edu.
Journal of Virology, March 2002, p. 2890-2898, Vol. 76, No. 6
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.6.2890-2898.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Buchkovich, N. J., Maguire, T. G., Paton, A. W., Paton, J. C., Alwine, J. C.
(2009). The Endoplasmic Reticulum Chaperone BiP/GRP78 Is Important in the Structure and Function of the Human Cytomegalovirus Assembly Compartment. J. Virol.
83: 11421-11428
[Abstract]
[Full Text]
-
Boehme, K. W., Guerrero, M., Compton, T.
(2006). Human Cytomegalovirus Envelope Glycoproteins B and H Are Necessary for TLR2 Activation in Permissive Cells. J. Immunol.
177: 7094-7102
[Abstract]
[Full Text]
-
Sadaoka, T., Yamanishi, K., Mori, Y.
(2006). Human herpesvirus 7 U47 gene products are glycoproteins expressed in virions and associate with glycoprotein H.. J. Gen. Virol.
87: 501-508
[Abstract]
[Full Text]
-
Akkapaiboon, P., Mori, Y., Sadaoka, T., Yonemoto, S., Yamanishi, K.
(2004). Intracellular Processing of Human Herpesvirus 6 Glycoproteins Q1 and Q2 into Tetrameric Complexes Expressed on the Viral Envelope. J. Virol.
78: 7969-7983
[Abstract]
[Full Text]
-
Mori, Y., Akkapaiboon, P., Yonemoto, S., Koike, M., Takemoto, M., Sadaoka, T., Sasamoto, Y., Konishi, S., Uchiyama, Y., Yamanishi, K.
(2004). Discovery of a Second Form of Tripartite Complex Containing gH-gL of Human Herpesvirus 6 and Observations on CD46. J. Virol.
78: 4609-4616
[Abstract]
[Full Text]
-
Compton, T., Kurt-Jones, E. A., Boehme, K. W., Belko, J., Latz, E., Golenbock, D. T., Finberg, R. W.
(2003). Human Cytomegalovirus Activates Inflammatory Cytokine Responses via CD14 and Toll-Like Receptor 2. J. Virol.
77: 4588-4596
[Abstract]
[Full Text]
-
Mori, Y., Akkapaiboon, P., Yang, X., Yamanishi, K.
(2003). The Human Herpesvirus 6 U100 Gene Product Is the Third Component of the gH-gL Glycoprotein Complex on the Viral Envelope. J. Virol.
77: 2452-2458
[Abstract]
[Full Text]
-
Rasmussen, L., Geissler, A., Cowan, C., Chase, A., Winters, M.
(2002). The Genes Encoding the gCIII Complex of Human Cytomegalovirus Exist in Highly Diverse Combinations in Clinical Isolates. J. Virol.
76: 10841-10848
[Abstract]
[Full Text]